Market revenue in 2024 | USD 450.6 million |
Market revenue in 2030 | USD 762.4 million |
Growth rate | 9.2% (CAGR from 2025 to 2030) |
Largest segment | Other tests |
Fastest growing segment | Other tests |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Extractable and leachable, Material characterization, Physical testing, Bioburden testing, Sterility testing, Other tests |
Key market players worldwide | SGS AG, Labcorp Holdings Inc, Eurofins Scientific SE, Intertek Group PLC, Wuxi AppTec Co Ltd, Inotiv Inc, Charles River Laboratories International Inc, Pace Analytical Services, NAMSA, Medical Device Testing Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to medical device analytical testing outsourcing market will help companies and investors design strategic landscapes.
Other tests was the largest segment with a revenue share of 20.02% in 2024. Horizon Databook has segmented the China medical device analytical testing outsourcing market based on extractable and leachable, material characterization, physical testing, bioburden testing, sterility testing, other tests covering the revenue growth of each sub-segment from 2018 to 2030.
China is one of the most technologically advanced countries, which significantly contributes to the healthcare industry. In addition, rise in geriatric population and presence of a large proportion of population belonging to the middle-income group increases the demand for innovative & cost-effective medical equipment, which is expected to attract key medical devices companies.
China is likely to grow at a lucrative rate over the forecast period due to presence of local manufacturers and large workforce. The market is also supported by increase in the number of collaborations between industry players and Original Equipment Manufacturers (OEMs) in the country.
OEMs in China majorly focus on leveraging services that help reduce product recalls and minimize time taken for regulatory approvals. Moreover, lower costs associated with the production and maintenance of products with international quality standards make China a preferred country for outsourcing various services by prominent industry players.
Horizon Databook provides a detailed overview of country-level data and insights on the China medical device analytical testing outsourcing market , including forecasts for subscribers. This country databook contains high-level insights into China medical device analytical testing outsourcing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account